Dhanlaxmi Crop Science Fund Raise of ₹23.8 Cr

Dhanlaxmi Crop Science Other Announcement

Dhanlaxmi Crop Science filed its Reg 32 IPO fund-use statement for the half year ended September 2026. No deviation is reported.

Dhanlaxmi Crop Science Annual General Meeting

Dhanlaxmi Crop Science Limited held its 21st Annual General Meeting on September 30, 2026. Shareholders transacted ordinary and special business items.

Dhanlaxmi Crop Science Annual General Meeting

Dhanlaxmi Crop Science Limited has scheduled its 21st Annual General Meeting for September 30, 2026. The meeting will address the adoption of financial statements and director appointments.

Dhanlaxmi Crop Science Board Meeting Outcome

Dhanlaxmi Crop Science held a board meeting approving the 21st Annual General Meeting date, the Director's Report, and new director appointments.

Dhanlaxmi Crop Science Business Update

Dhanlaxmi Crop Science received regulatory approval to sell various hybrid and varietal field crop seeds in Chhattisgarh, strengthening its market presence in the region.

Dhanlaxmi Crop Science Other Announcement

Dhanlaxmi Crop Science Limited has appointed Fin portal Investments Private Limited as its Investor Relations agency effective August 1, 2026.

Amba Auto Sales and Services Fund Raise of ₹161.6 Cr

Amba Auto board approved a preferential issue of up to 1.60 crore warrants at Rs 101 each. The issue aggregates Rs 161.60 Crore, subject to shareholder approval.

Value

₹161.6 Cr

Jindal Capital Fund Raise of ₹16.22 Cr

Jindal Capital's board approved a rights issue of 1,08,12,149 shares at Rs.15 each, raising Rs.16.22 Crore. The issue ratio is 3:2, with record date 06 November 2026.

Value

₹16.22 Cr

Rajkot Investment Trust Fund Raise of ₹48 Cr

Rajkot Investment Trust's board approved a Rs 48 Crore rights issue of equity shares. Pricing and record date will be set later by a committee.

Value

₹48.00 Cr

U Y Fincorp Fund Raise of ₹187.2 Cr

U.Y. Fincorp's board approved preferential issues of warrants and equity shares aggregating Rs 187.17 Crore. The issue is subject to shareholder and regulatory approvals.

Value

₹187.2 Cr

Rite Zone Chemcon India Fund Raise of ₹6.58 Cr

Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.

Value

₹6.58 Cr

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr